14159 capital (GP), LLC Insider Trading
Get free email notifications about insider trading for 14159 capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of 14159 capital (GP), LLC. 14159 capital (GP), LLC is a 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and a 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in INCYTE CORP ($INCY) and a 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and a 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and a 10% Owner in VIROPHARMA INC ($VPHM) and a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a 10% Owner in ADOLOR CORP ($ADLR) and a 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and a 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and a Director in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Address: 667 MADISON AVENUE, 17TH FLOOR NEW YORK US 10021 NY
Companies in which 14159 capital (GP), LLC is an Insider
ADOLOR CORP
Trading Symbol: ADLRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 186,272 shares
Latest Transaction: Oct 29 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALLOS THERAPEUTICS INC
Trading Symbol: ALTHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 190,917 shares
Latest Transaction: Feb 06 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ardea Biosciences, Inc./DE
Trading Symbol: IBPIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: Director, 10% Owner
Holdings: 93,282 shares
Latest Transaction: Jan 24 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AUXILIUM PHARMACEUTICALS INC
Trading Symbol: AUXLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 149,968 shares
Latest Transaction: Mar 31 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOCRYST PHARMACEUTICALS INC
Trading Symbol: BCRXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 120,828 shares
Current Value: $685,095
Latest Transaction: Jun 01 2009
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOMIC HEALTH INC
Trading Symbol: GHDXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of 14159 capital (GP), LLC: Director
Holdings: 152,640 shares
Current Value: $4,196,074
Latest Transaction: Mar 08 2011
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HERON THERAPEUTICS, INC. /DE/
Trading Symbol: HRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Apr 26 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDERA PHARMACEUTICALS, INC.
Trading Symbol: IDRAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 12,867 shares
Current Value: $20,073
Latest Transaction: Jul 30 2008
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Trading Symbol: INCYIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of 14159 capital (GP), LLC: Director
Holdings: 237,497 shares
Current Value: $28,067,395
Latest Transaction: Sep 23 2010
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of 14159 capital (GP), LLC: Director
Holdings: 303,449 shares
Current Value: $18,446,665
Latest Transaction: Feb 04 2011
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNAGEVA BIOPHARMA CORP
Trading Symbol: GEVAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of 14159 capital (GP), LLC: Director
Holdings: 384 shares
Latest Transaction: Sep 30 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TAPESTRY PHARMACEUTICALS, INC
Trading Symbol: NPROIndustry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Oct 17 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VIROPHARMA INC
Trading Symbol: VPHMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 248,829 shares
Latest Transaction: May 10 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of 14159 capital (GP), LLC
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, SGEN, GEVA, NPRO, VPHM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Option Exercise | P | 1,000.00 | 10,800 | 10,800,000 | 10,800 | |
Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Option Exercise | P | 0.04 | 5,400 | 216 | 5,400 | |
Feb 04 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 15.50 | 48,197 | 747,054 | 303,449 | 255.3 K to 303.4 K (+18.88 %) |
Mar 08 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.13 | 50 | 1,256 | 152,640 | 152.6 K to 152.6 K (+0.03 %) |
Mar 08 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 24.90 | 6,715 | 167,204 | 152,590 | 145.9 K to 152.6 K (+4.60 %) |
Mar 08 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.39 | 955 | 24,249 | 145,875 | 144.9 K to 145.9 K (+0.66 %) |
Mar 08 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.40 | 537 | 13,642 | 144,920 | 144.4 K to 144.9 K (+0.37 %) |